Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Downgrades National Health Investors Inc(NHI.US) to Hold Rating, Raises Target Price to $86
National Health Investors Downgraded to Equal Weight From Overweight at Wells Fargo
BofA Securities Initiates National Health Investors Inc(NHI.US) With Buy Rating, Announces Target Price $92
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $92
National Health Investors Price Target Raised to $78.00/Share From $65.00 by Truist Securities
National Health Investors Analyst Ratings
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $90
Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $81
KeyBanc Initiates National Health Investors Inc(NHI.US) With Hold Rating
Buy Rating Justified by National Health Investors' Strong Q2 Financials and Growth Prospects
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Global Net Lease (GNL)
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $80
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Postal Realty (PSTL)
National Health Investors Analyst Ratings
Truist Securities Adjusts Price Target on National Health Investors to $65 From $58, Maintains Hold Rating
National Health Investors Analyst Ratings
Wells Fargo Reaffirms Their Buy Rating on National Health Investors (NHI)
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI), Realty Income (O) and Alexander's (ALX)